logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


20 New IPOs for Week of July 28

By  +Follow July 28, 2014 1:53PM
Share:
Tickers Mentioned:

Full IPO calendar & reports HERE.  In order of largest IPO first:

 

(1) Based in Stamford, CT, Synchrony Financial (SYF) scheduled a $3.06 billion IPO on the NYSE with a market capitalization of $20.3 billion at a price range midpoint of $24 for Thursday, July 31, 2014.

SYF is one of the premier consumer financial services companies in the United States. It's the old GE Capital.

 

(2) Based in Somerset, NJ, Catalent (CTLT) scheduled a $871 million IPO on the NYSE with a market capitalization of $2.4 billion at a price range midpoint of $20.50 for Thursday, July 31, 2014.

CTLT is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.

 

(3) Based in Jerusalem, Israel, Mobileye N.V. (MBLY) scheduled a $500 million IPO on the NYSE with a market capitalization of $3.8 billion at a price range midpoint of $18 for Friday, August 1, 2014.

MBLY is the global leader in the design and development of software and related technologies for camera-based Advanced Driver Assistance Systems (“ADAS”).

 

(4) Based in London, United Kingdom, VTTI Energy Partners LP  (VTTI) scheduled a $350 million IPO on the NYSE, with a market capitalization of $402 million at a price range midpoint of $20 for Friday, August 1, 2014.

VTTI is a fee-based, growth-oriented limited partnership formed in April 2014 by VTTI, one of the world’s largest independent energy terminaling businesses, to own, operate, develop and acquire refined petroleum product and crude oil terminaling and related energy infrastructure assets on a global scale.

 

(5) Based in Aberdeen, United Kingdom,Transocean Partners (RIGP) scheduled a $350 million IPO on the NYSE with a market capitalization of $827 million at a price range midpoint of $20 for Thursday, July 31, 2014.

RIGP is a growth-oriented limited liability company recently formed by Transocean,one of the world’s largest offshore drilling contractors, to own, operate and acquire modern, technologically advanced offshore drilling rigs.

 

(6) Based in Houston, TX, Westlake Chemical Partners LP (WLKP) scheduled a $225 million IPO on the NYSE with a market capitalization of $508 milliion at a price range midpoint of $20 for Wednesday, July 30, 2014.

WLKP is a Delaware limited partnership recently formed by Westlake to operate, acquire and develop ethylene production facilities and related assets.

 

(7) Based in Weston, FL, FCB Financial Holdings (FCB) scheduled a $223 million IPO on the NYSE with a market capitalization of $1.02 billion at a price range midpoint of $25.50 for Friday, August 1, 2014.

 

(8) Based in Oakbrook Terrace, IL, SIRVA (SRVA) scheduled a $186 million IPO on the Nasdaq with a market capitalization of $632 million at a price range midpoint of $16 for Friday, August 1, 2014.

SRVA is a moving/relocation company.

 

(9) Based in North Billerica, MA, Lantheus Holdings (LNTH) scheduled a $125 million IPO on the Nasdaq with a market capitalization of $370 million at a price range midpoint of $13.50 for Wednesday, July 30, 2014.

LNTH is a global leader in developing, manufacturing, selling and distributing innovative diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases.

 

(10) Based in Draper, UT, Health Equity (HQY) scheduled a $100 million IPO on the Nasdaq with a market capitalization of $546 million at a price range midpoint of $11 for Thursday, July 31, 2014.

HQY is a leader and an innovator in the high growth category of technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions.

 

(11) Based in Or Yehuda, Israel, Vascular Biogenics (VBLX) scheduled a $76 million IPO on the Nasdaq with a market capitalization of $259 million at a price range midpoint of $14 for Thursday, July 31, 2014.

VBLX is a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of first-in-class treatments for cancer and immune-inflammatory diseases.

 

(12) Based in Menlo Park, CA, Avalanche Biotechnologies (AAVL) scheduled a $76 million IPO on the Nasdaq with a market capitalization of $292 million at a price range midpoint of $14 for Thursday, July 31, 2014.

AAVL is a clinical-stage biotechnology company focused on discovering and developing novel gene therapies to transform the lives of patients with sight-threatening ophthalmic diseases.

 

(13) Based in Zug, Switzerland, Auris Medical Holding AG (EARS) scheduled a $76 million IPO on the Nasdaq with a market capitalization of $283 million at a price range midpoint of $11 for Friday, August 1, 2014.

EARS is a clinical-stage biopharmaceutical company focused on the development of novel products for the treatment of inner ear disorders.

 

(14) Based in Petach Tikva, Israel, Macrocure (MCUR) scheduled a $75 million IPO on the Nasdaq with a market capitalization of $264 million at a price range midpoint of $14 for Thursday, July 31, 2014.

MCUR is a regenerative medicine company focused on developing, manufacturing and commercializing novel cell therapy products to address unmet needs in the treatment of chronic and other hard-to-heal wounds.

 

(15) Based in Fremont, CA, Zosano Pharma (ZSAN) scheduled a $70 million IPO on the Nasdaq with a market capitalization of $134 million at a price range midpoint of $11 for $134 million for the week of July 28th.

ZSAN is a clinical stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver its proprietary formulations of existing drugs through the skin for the treatment of a variety of indications.

 

(16) Based in South San Francisco, CA, Tobira Therapeutics (TBRA) scheduled a $60 million IPO on the Nasdaq with a market capitalization of $143 million at a price range midpoint of $13 for Thursday, July 31, 2014.

TBRA is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat liver disease, human immunodeficiency virus, or HIV, fibrosis and inflammation.

 

(17) Based in Stamford, CT, Loxo Oncology (LOXO) scheduled a $57 million IPO on the Nasdaq with a market capitalization of $196 million at a price range midpoint of $13 for Friday, August 1, 2014.

LOXO develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations.

 

(18) Based in New Haven, CT, Marinus Pharmaceuticals (MRNS) scheduled a $52 million IPO on the Nasdaq with a market capitalization of $159 million at a price range midpoint of $13 for Thursday, July 31, 2014.

MRNS is a clinical stage biopharmaceutical company focused on developing and commercializing innovative neuropsychiatric therapeutics.

 

(19) Based in Tel Aviv, Israel, Bio Blast Pharma Ltd. (ORPN) scheduled a $40 million IPO on the Nasdaq with a market capitalization of $172 million at a price range midpoint of $172 for Friday, Aug. 1, 2014.

ORPN is a development-stage biopharmaceutical company focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases.

 

(20) Based in Yonker, NY, ContraFect (CFRXU) scheduled a $20 million IPO on the Nasdaq with a market capitalization of $96 million at a price range midpoint of $5.50 for Tuesday, July 29, 2014.

CFRXU is a biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Signup for our daily newsletter and get our best articles emailed right to you!

Results for SYF
InvestWithConf
26 May 15 17:44:03
$SYF is rated BUY, 6.0% upside by Wall Street analysts based on average ratings/targets http://t.co/ttC6Bz63H4 http://t.co/iMXsLaSlWK
Breaking News Now
26 May 15 01:23:03
$SYF: Synchrony Financial Sees Large Increase in Short Interest (SYF): http://t.co/jRoJmDye6O
The Legacy News
26 May 15 01:22:18
Synchrony Financial Sees Large Increase in Short Interest $SYF http://t.co/NHUayRyHNZ
Dakota Financial
26 May 15 00:38:56
Short Interest in Synchrony Financial Increases By 94.9% $SYF http://t.co/2KdZuDgGow
Ticker Report
26 May 15 00:28:24
Short Interest in Synchrony Financial Increases By 94.9% $SYF http://t.co/j1OMjGzC9a
ProTradersNews
26 May 15 00:28:02
$SYF: Short Interest in Synchrony Financial Increases By 94.9% (SYF): http://t.co/FmllINHgKg
US Banking News
26 May 15 00:26:18
Short Interest in Synchrony Financial Increases By 94.9% $SYF http://t.co/10MS9GCqV0
Capital Market Labs
25 May 15 12:32:49
$SYF Revenue is Expanding. #CML_SYF #CML_Revenue http://t.co/MEXRTQ0v2n http://t.co/XAohSZh9qP
Capital Market Labs
24 May 15 08:49:01
$SYF Revenue is Rising. #CML_SYF #CML_Revenue http://t.co/YjFa3lWzCa http://t.co/uqBcnBi9Sx
Capital Market Labs
23 May 15 17:04:21
$ALLY vs. $SYF vs. $AXP vs. $SC Compared Across 9 Critical Measures http://t.co/oEoRtxBGyZ http://t.co/PUyCSCP6KX
Sleek Money
23 May 15 06:05:44
Synchrony Financial Given BBB Credit Rating $SYF http://t.co/qfVFzSvQvs
Capital Market Labs
23 May 15 05:40:12
Largest Diversified Financials Operating Margin $ICE $SYF $GS $IVZ $BLK Chart: http://t.co/NOQEbrWh8Y http://t.co/i4mqK7fMZj
Analyst Ratings
22 May 15 04:37:27
Get the latest ratings for $CVGW $RNR $AWH $SYF $EW in your inbox with ARN Daily http://t.co/nSJuDsYidj
Capital Market Labs
21 May 15 16:38:34
$SYF Revenue is Growing. #CML_SYF #CML_Revenue http://t.co/YjFa3lWzCa http://t.co/UmXmhUCxTM
dailystockplays.com
21 May 15 14:45:09
CMF Improving http://t.co/cW4r2rgwa9 $ALLY $SGEN $AVY $MTOR $EWBC $GM/WT/A $SYF $AEC $UNT $FLOT $BYDDF $UAM $MRCC $EMHY $FGB $HFWA $GCH $GSY
StockNewsWires
21 May 15 09:42:03
$ACHC $YDLE $CMCSA $CLDT $JBLU $SYF $GE $ODFL $OCR $CVS: Happy Peak Proxy Day (2015 Edition)!: http://t.co/W3M5kVDSP7
clayton
20 May 15 20:28:07
SYF 32.65 Synchrony Financial $SYF added to my watch list. Right now with SYF I am watching the last price 32. http://t.co/q6TP3HfUnT
IPODave
20 May 15 06:54:39
Will play $BKFS like $SYF. Hold common until options are issued--switch to ITM leaps.
Bharat (Brad) Talwar
20 May 15 06:40:59
@jimcramer @TheStreetTV here goes, what are your thoughts on $SYF. I bought it when it came public, stock is up. Hold or Sell, gracias
Financescom-stocks
20 May 15 05:37:07
$SYF Synchrony Financial Announces Winners of "Buy It. Snap It. Win It." Contest http://t.co/cdvmSfxj78
dailystockplays.com
19 May 15 14:51:48
MACD Bearish http://t.co/9vIt5R0kFh $FXA $MSM $RDS/B $SYF $PSHZF $UDN $RDC $BSCF $EPIQ $WNC $OCN $CPAC $CLD $CNTY $HPJ $SFXE $SAND $SMT
Capital Market Labs
19 May 15 13:15:28
$SYF Revenue is Rising. #CML_SYF #CML_Revenue http://t.co/YjFa3lWzCa http://t.co/PrcBDy66j0
BreakingStocksNews
19 May 15 09:53:03
$SYF: Stock in Motion: Synchrony Financial (NYSE:SYF): http://t.co/CMkrfXdyOB
Penny Stock Secret
18 May 15 21:48:51
Ranks #1 with over 80% in alert gains today. Click here http://t.co/NovWYe2RAx .. $SYF $SYK $SYT
Víctor
18 May 15 13:05:53
RT @SeekingAlpha: Synchrony Financial: The Expense Build Is A Short-Term Headwind http://t.co/KhFWngZSFR $GE $SYF
Financial Stocks
18 May 15 12:58:46
Synchrony Financial: The Expense Build Is A Short-Term Headwind http://t.co/vY0P21xViX $GE $SYF
Long & Short Ideas
18 May 15 12:58:45
Synchrony Financial: The Expense Build Is A Short-Term Headwind http://t.co/Xu70Ra1Z7f $GE $SYF
Seeking Alpha
18 May 15 12:58:45
Synchrony Financial: The Expense Build Is A Short-Term Headwind http://t.co/KhFWngZSFR $GE $SYF
Dakota Financial
18 May 15 05:24:59
Synchrony Financial Given “BBB” Credit Rating by Morningstar $SYF http://t.co/4U2aBJJPYm
				
				
By  +Follow July 28, 2014 1:53PM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register

LOG IN